Leicester Tuberculosis Research Group

Integrating science and medicine to overcome tuberculosis

LTBRG triangle.JPGThe Leicester Tuberculosis Research Group (LTBRG) is a transdisciplinary body comprising basic scientists and academic clinicians that is focused on the discovery, development and implementation of knowledge to overcome the health, economic and social impact of tuberculosis (TB) at a local, national and ultimately global level.

Our research areas include clinical disease expression, characterising phenotypes of bacterial physiology, defining immunological markers of disease and defining the complex relationships that exist between these domains. The broad impact of this work includes discovery of novel drug and diagnostic/prognostic targets, determination of immune responses that can inform effective vaccine development as well as biomarkers that offer better characterisation of the host-pathogen relationship, with implementation of this knowledge in experimental medicine studies of transmission and clinical studies of treatment effectiveness.

We have unique access to well characterised clinical cohorts with active TB and latent infection (LTBI). Epidemiological studies previously undertaken in these groups has informed national policy change, including the launch in 2015 of a National TB Strategy for England. We have the proven capacity to link bacterial genotyping and physiology to outbreak management. We are developing models of transmission that are entirely novel and involve a multidisciplinary group of engineers, aero-biologists, bacterial physiologists, biological chemists and immunologists. We are pursuing local and international studies of human immunological responses and have overseas connections and collaborations in South Africa, Brazil, The Gambia, China, Kyrgyzstan and India.

Share this page:

Contact

For enquiries about the Leicester TB Research Group, please contact Professor Andea Cooper amc72@le.ac.uk